Article Sidebar
Article Details
Issue
Section
Articles
A. AFRICAN HEALTH SCIENCES OPEN ACCESS POLICY
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
Bacteriological profile of neonatal septicaemia in a tertiary hospital in Nigeria
Abstract
Background: Neonatal septicaemia is an important cause of morbidity and mortality. Knowledge of the bacteriological profile of the aetiologic agents is very important and helps to reduce the associated mortality in neonatal septicaemia.
Objective: To determine the bacteriological profile of common aetiologic agents of neonatal septicaemia and their antibiotics sensitivity pattern.
Method: This study was a retrospective review of all the 390 neonatal blood cultures carried out in the Department of Clinical Microbiology and Parasitology of the National Hospital Abuja, Nigeria over three years (Jan 2002 – Dec 2004).
Result: The 390 neonatal samples constituted 25% of all blood samples received in the laboratory during the period under review. Twenty-two percent were positive for bacterial growth, yielding gram-negative bacilli (GNB) and grampositive cocci (GPC) in almost equal proportion, predominantly Klebsiella pneumoniae (86% of GNB) and Staphylococcus aureus (81% of GPC). Although the Klebsiella pneumoniae were multiply-resistant and showed resistance pattern suggestive of Extended-Spectrum Beta Lactamase (ELBS) production they were 100% sensitive to imipenem. The sensitivity of the Staphylococcus aureus isolates to amoxicillin-clavulanic acid, cefuroxime, ciprofloxacin, chloramphenicol and erythromycin were 89%, 85%, 75%, 71% and 64% respectively.
Conclusion: A sustainable antibiotic susceptibility surveillance programme coupled with good infection control practices and rational antibiotics use will reduce infection rate, ensure better therapeutic success and prolong the efficacy of available antimicrobials.
Keywords: neonates, septicaemia, antibiotic susceptibility, Nigeria
African Health Sciences Vol. 6(3) 2006: 151-154
Objective: To determine the bacteriological profile of common aetiologic agents of neonatal septicaemia and their antibiotics sensitivity pattern.
Method: This study was a retrospective review of all the 390 neonatal blood cultures carried out in the Department of Clinical Microbiology and Parasitology of the National Hospital Abuja, Nigeria over three years (Jan 2002 – Dec 2004).
Result: The 390 neonatal samples constituted 25% of all blood samples received in the laboratory during the period under review. Twenty-two percent were positive for bacterial growth, yielding gram-negative bacilli (GNB) and grampositive cocci (GPC) in almost equal proportion, predominantly Klebsiella pneumoniae (86% of GNB) and Staphylococcus aureus (81% of GPC). Although the Klebsiella pneumoniae were multiply-resistant and showed resistance pattern suggestive of Extended-Spectrum Beta Lactamase (ELBS) production they were 100% sensitive to imipenem. The sensitivity of the Staphylococcus aureus isolates to amoxicillin-clavulanic acid, cefuroxime, ciprofloxacin, chloramphenicol and erythromycin were 89%, 85%, 75%, 71% and 64% respectively.
Conclusion: A sustainable antibiotic susceptibility surveillance programme coupled with good infection control practices and rational antibiotics use will reduce infection rate, ensure better therapeutic success and prolong the efficacy of available antimicrobials.
Keywords: neonates, septicaemia, antibiotic susceptibility, Nigeria
African Health Sciences Vol. 6(3) 2006: 151-154
